Anti-Snoring Devices & Snoring Surgery Market Worth $1.8 Billion By 2024

Global anti-snoring devices and snoring surgery market is expected to reach USD 1.84 billion by 2024, according to a new report by Grand View Research, Inc. The anti-snoring devices and snoring surgery market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing awareness levels about the ill effects of snoring, rising elderly and obese population, the presence of an unexploited consumer base, and the increasing consumption of alcohol and cigarettes. However, factors such as the cost prohibitive nature of the products, limited efficacy of the presently available treatments, and the presence of an unpropitious reimbursement scenario are likely to hinder the growth of the market.

The market is segmented into anti-snoring devices and snoring surgery segments. The anti-snoring devices segment includes oral appliances, nasal devices, position control devices, chin straps, tongue stabilizing devices, and expiratory positive airway pressure therapy devices. The surgery segment includes uvulopalatopharyngoplasty, laser-assisted uvulopalatoplasty, radiofrequency ablation, sclerotherapy, pillar procedure, and others. North America and Europe are the major shareholders of this industry due mainly to the increasing awareness associated with available treatment options and the eventual rise in popularity and adoption of these products. The Asia Pacific region is expected to witness high growth as a consequence of the untapped population base characterized with a snoring condition, higher levels of awareness regarding the effects of snoring, and the presence of well-established players in the sector. 

Click the link below:
http://www.grandviewresearch.com/industry-analysis/anti-snoring-devices-snoring-surgery-market

Further key findings from the study suggest:

  • North America is estimated to lead the industry with the largest market share in 2015.This growth is attributed to the rapidly increasing popularity and the resultant high market penetration of such treatment devices. Asia Pacific is expected to exhibit the highest growth rate owing to the large untreated population and the rising awareness levels with regard to treatment options and the notorious health consequences associated with this condition.
  • In surgery, somnoplasty is estimated to be the fastest growing segment due largely to factors, such as low cost, reduced surgical trauma, less invasive, and chances of fewer complications in comparison to the traditional surgery procedures
  • The anti-snoring devices and snoring surgery market comprises several local as well as global players. Some key market players include Tomed Dr. Toussaint GmbH, Apnea Sciences Corporation, and Meditas Ltd., among others. The companies have adopted several organic and inorganic strategies in order to gain prominence in this sector. A few of these strategies include geographic expansion, new product launches, new product development, partnerships, collaborations, and mergers and acquisitions, among others. For instance, in March 2015, Meditas Ltd. launched nasal dilators for uninterrupted flow of air. 

Health Information Exchange Market Worth $2.21 Billion By 2024

The global healthcare information exchange market size is expected to reach USD 2.21 billion by 2024, according to a new report by Grand View Research, Inc. The increasing need for greater access to patient health information is a potent driver of the health information exchange (HIE) market. Additionally, the increasing awareness pertaining to the HIE owing to the presence of government and non-profit organizations, such as Healthcare Information and Management Systems Society (HIMSS), is the major factor expected to drive the growth of the aforementioned industry over the forecast period.

Furthermore, the increasing focus towards advanced healthcare solutions along with the increased provision of funds from government organizations to expand healthcare information systems is expected to increase the adoption of HIE systems in the near future. For example, the presence of the Agency for Healthcare Research and Quality (AHRQ), which is instrumental in providing funds pertinent to HIE implementation in the U.S.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/health-information-exchange-hie-market

Further Key Findings From the Study Suggest:

  • The private HIE segment dominated the setup type segment with respect to the revenue share of over 52.0% in 2015. This dominance is attributed to presence of larger number of service providers and higher cost efficiency in the above-mentioned segment.
  • Under the category of implementation model of HIE, the hybrid model segment is anticipated to grow at a lucrative rate due to the associated benefits, such as improved patient care delivery and enhanced operational efficiency of the practices
  • Kentucky HIE is a hybrid model implemented with an objective to provide patient information related to chronic disease management and preventive health via messaging, alerts, and other communication tools. Kentucky HIE also connects to the National Health Information Network (NHIN) and enables interoperability across various health systems.
  • On the basis of solution type, the platform-centric segment is expected to grow at a rapid growth rate in 2015. This can be attributed to the benefits associated with platform-centric solutions, such as storage of colossal amounts of data and facilitated HIE, thus the implied demand for the products in the health information exchange market.
  • In terms of applications, the internal interfacing segment is the fastest growing segment. The increasing need to connect with a larger number of patients through the use of patient engagement tools and internal interfacing is presumed to propel the demand for the HIE market.
  • As of 2015, North America dominated the HIE market at over 45.0% owing to the presence of vast number of companies, supportive reimbursement policies, and the increasing implementation of EHR
  • Asia Pacific is expected to grow rapidly at a CAGR of over 10.5% during the forecast period due to the rising disposable income levels, the increased awareness levels amongst healthcare practitioners regarding the HIE systems, the presence of outsourced HIE service providers, and the rising investments in the healthcare industry by the major players
  • Some key players in this sector are GE Healthcare, eClinicalWorks, Siemens AG, Orion Health, Inc., Medicity, Inc., IBM Corporation, CareEvolution, Inc., Cerner Corporation, RelayHealth Corporation, and Allscripts Healthcare Solutions, Inc.
  • The industry players are involved in strategic collaborations and mergers & acquisitions. The participants are striving to gain market penetration via offering end-to-end customized services to the potential consumers. For instance, in March 2016, Allscripts Healthcare Solutions, Inc. and AssistRX, Inc. entered into a partnership agreement to develop technologically advanced HIE solutions with enhanced speed and efficiency in prescribing specialty medications in the U.S.

Protein Labeling Market Size Worth $2.60 Billion By 2024

The global protein labeling market size is expected to reach USD 2.60 billion by 2024, according to a new report by Grand View Research, Inc., registering a CAGR of 9.3% during the forecast period. Development and commercial launch of high accuracy and rapid labeling products is expected to enhance market growth.

Post-translation Modification (PTM) such as proteolysis, lipidation, acetylation, methylation, nitrosylation, ubiquitination, glycosylation, and phosphorylation influence all aspects of pathogenesis as well as normal cell functioning. PTM studies are rapidly being adopted to investigate biological functions of various proteins and their role in disease prognosis.

Availability of a broad range of labels for covalent attachment of different molecules provides researchers the choice to select labels to suit specific applications. Fluorescent labeling does not require additional reagents for protein detection due to its ability to respond to light signals. This ability of fluorescence molecules has significantly contributed to its rapid adoption in in vivo protein labeling.

High R&D spending to reduce complexity in protein labeling and increased adoption of sophisticated bioengineering techniques in various sectors of biotechnology further contribute to market growth. Development of rapid diagnostic tests based on detection of the presence of specific protein proves to be of great significance for rapid and cost-effective diagnostics. Focus on development of advanced diagnostic tests based on protein detection is expected to fuel new product development.

Technological advancements in genetic sequencing methodologies has drastically reduced the cost of genome profiling. This is expected to drive demand for protein expression analysis, which is the next step in genetic analysis after sequencing. Declining sequencing cost has increased the number of proteomic and genomic profiling studies, which is projected to fuel demand for protein labeling over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/protein-labeling-market

Further key findings from the report suggest:

  • Rapid adoption of post-translational modification studies in proteomics is expected to fuel demand for reagents
  • SNAP-, CLIP-, MCP-, and ACP- tags are some of the fusion proteins used for covalent labeling. Ability to provide irreversible covalent labeling and labeling for membrane protein drives demand for probes/tags in labeling
  • Demand for kits for clinical diagnosis of various diseases based on protein detection fuels the kits product segment
  • North America dominated the market due to presence of key players and high investments in proteomics research. Canada is poised to witness lucrative growth owing to increasing number of research projects focused on improving healthcare solutions
  • Europe is a key regional market. The Seventh Framework Program of the European Union provided funds for P-CUBE – an infrastructure for Protein Production Platforms to provide access to most advanced techniques to researchers
  • Asia Pacific is expected to observe remarkable growth over the forecast period, especially in China and Japan
  • Major companies operating in the market include F. Hoffmann-La Roche AG; GE Healthcare Life Science; Promega Corporation; PerkinElmer Inc.; Merck Millipore; Thermo Fisher Scientific Inc.; Kirkegaard & Perry Laboratories (KPL); Eurogentec S.A.; New England Biolabs; and LI-COR Inc.
  • Key players are involved in acquisition of smaller players and are expanding their product portfolio, resulting in market consolidation.

North America PoC Diagnostics Market Worth $8.95 Billion By 2024

The North America point of care diagnostics market is anticipated to reach USD 8.95 billion by 2024, according to a new report by Grand View Research, Inc. Incorporation of advanced information technology solutions coupled with the launch of innovative POC products with automation and ease of use is projected to influence market progression during the forecast period. 

Moreover, the rising adoption rate of the POC devices in order to obtain quick results for immediate decision making for patient management is expected to provide the market with lucrative growth avenues. Additionally, the regulatory initiatives introduced for patient care management and rising prevalence of various diseases is attributive to boost demand for these products in the coming years.

The presence of a favorable funding environment in the region is attributive to drive R&D in academic organizations and universities thereby resulting to industrial progress through to 2024.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/north-america-point-of-care-poc-diagnostics-market

Further key findings from the report suggest: 

  • Glucose testing accounted for the largest share of over 41% of the market in 2015 with respect to revenue generation. Factors attributive for the estimated large share includes presence of comprehensive product portfolio provided by the local as well as international market participants. Moreover, rise in the prevalence of diabetes in chronic patients and need for monitoring glucose levels is also supportive for revenue generation of this segment. 
  • Infectious diseases point-of-care tests are expected to witness the fastest growth in the coming years owing to the R&D carried out in this segment for an introduction of novel tests. Infectious disease testing segments include kits for various diseases such as HIV, HBV, respiratory syncytial virus (RSV), pneumonia or streptococcus associated infections, HPV, influenza/flu, HCV, MRSA, Clostridium difficile, TB &drug-resistant TB, and HSV. 
  • Cardiac markers are also anticipated to register substantial growth as a result of an increase in incidence rate of cholesterol associated disorders and rise in the number of cases of congestive heart failure. 
  • Clinics dominated the POC diagnostic market in 2015 due to higher usage of these tests in clinics. However, home settings for POC diagnostics are anticipated to witness the fastest growth owing to rising usage of home health care settings for disease monitoring in the geriatric population. 
  • Assisted living healthcare facilities are also anticipated to witness considerable growth during the forecast period due to the property of rapid diagnostic products to enable simple usage at primary care level and in remote settings even with no laboratory infrastructure 
  • Prominent players of this industry include Qiagen N.V., Spectral Diagnostics, Abbott Laboratories, Siemens Healthcare, Instrumentation Laboratory, Danaher Corporation, BioMerieux, Johnson & Johnson, Abaxis Inc., Roche Diagnostics, Alere Inc., Nova Biomedical, Nipro Diagnostics, and Trinity Biotech. 
  • Strategies adopted by the market players include mergers and acquisitions with the smaller entities operating in market for enhancement of the product portfolio. The participants are involved introduction of new solutions, and collaborations with heath care institutions in order to maintain their global presence. 

Automotive Sunroof Market Worth $11.12 Billion by 2025

The global automotive sunroof market size is expected to reach USD 11.12 billion by 2025, according to a new study by Grand View Research, Inc., expanding at a CAGR of 6.9% during the forecast period. Initially, the sunroof feature was limited only to luxury vehicles. However, its growing popularity among consumers prompted several automakers to consider it as a differentiating feature. Rising popularity of sunroof feature coupled with continual advancements in glass technology is anticipated to provide a significant boost to the market.

Demand for convertible cars has been plummeting since the past few years owing to factors such as lesser agility and safety and higher costs as compared to hardtop vehicles. When it comes to hardtop vehicles, demand for sport utility vehicles (SUVs) has been rising tremendously owing to benefits they offer, such as improved stability and safety coupled with better utility. Furthermore, SUVs are increasingly being fitted with sunroofs. This shift in consumer preference is estimated to boost the demand for glass sunroof systems.

Development of glass materials that can safeguard against ultra-violet (UV) rays has allowed automakers to introduce wider glass sunroof systems. Given that glass sunroof systems are now occupying a larger section of roof’s surface, they are allowing more light that is natural, thereby better illuminating the interiors of the automobiles and augmenting level of comfort for passengers. However, concerns regarding glass shattering in events of rollovers or accidents are poised to hinder the growth of the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/automotive-sunroof-market

Further key findings from the study suggest:

  • The glass sunroof segment dominated the market in 2016 owing to growing popularity of panoramic sunroofs. The segment is likely to command about 87.0% of the overall revenue by 2025.
  • While sunroof systems can enhance the aesthetic factor of automobiles, innovations such as solar sunroof systems can open opportunities to harness renewable energy and reduce carbon footprints of automobiles. Such innovations are projected to shape the future of the market
  • Sunroofs are being gradually offered in the mid-segment vehicles as an optional feature. The market for mid-segment vehicles is expected to progress at a CAGR of 7.0% during the forecast period.
  • Asia Pacific is expected to witness the highest CAGR of 7.8% during the same period. Rising automobile production and increasing demand for premium and luxury vehicles are contributing to the growth of the region.
  • Webasto Group; Inalfa Roof Systems Group B.V.; Inteva Products; Magna International Inc.; and AISIN SEIKI Co., Ltd. are some of the leading market players in the automotive sunroof market.

Microcontroller Socket Market Size To Reach $1.46 Billion By 2024

The global microcontroller socket market is expected to reach USD 1.46 billion by 2024, according to a new report by Grand View Research, Inc. The increasing development and growth of automation and re-automation in the emerging countries are expected to fuel the industry growth.

The growth of automation has led to miniaturization and digitization as well as facilitates dynamics in the field of technology. The increasing need of providing high performance with power efficiency has further led to the development of automation technology at a rapid pace. The increasing labor costs and the growing demand for higher quality have encouraged the industry participants to opt for automated equipment in the programming process.

Gradually reducing the package size in the microelectronics industry has also impacted the market growth in a positive manner. industry requirements, such as higher density, increased operating speed, and lower power, have driven packaging in the industry, which has further led to an enhanced demand within the market.

Furthermore, the demand for thinner, smaller, and lesser expensive device packaging has also encouraged manufacturers to control the programming cost. The increasing demand in automotive, consumer electronics, medical devices for more accurate data, and in military & defense for enhanced security has also encouraged the industry participants to further reduce the package size.

Intense competition in the market has led the industry participants to enhance the product quality and process technologies as per the market requirement. However, failure to develop new designs and delays in developing new products with advanced technology may adversely affect the manufacturer market.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/microcontroller-socket-market

Further key findings from the report suggest:

  • The microcontroller socket market is expected to boost over the forecast period owing to the increasing microcontroller applications in various segments
  • The QFP socket is expected to grow at a CAGR of over 7% from 2016 to 2024, owing to the growing trend of automation and re-automation in the emerging countries
  • The automotive segment is projected to dominate over the forecast period owing to the huge application of the socket in the manufacturing of automobiles, such as body electronics, for enhancing driver safety
  • The majorindustry players in the microcontroller socket market include Texas Instruments, Aries Electronics, Mill-Max Manufacturing Corporation, and Samtec, Inc.

Anti-drone Market Size Worth $4.5 Billion By 2026

The global anti-drone market size is expected to reach USD 4.5 billion by 2026, expanding at a CAGR of 29.9% from 2019 to 2026, according to a new report by Grand View Research, Inc. The industry is rapidly growing due to rising concerns over the potential security threats from unauthorized aircrafts systems among both the civilian and military sectors. Increasing number of security violation incidents by such unauthorized unmanned aerial vehicles (UAVs), coupled with the rise in terrorism and illegal activities, has majorly driven the market over the last few years.

There has been a sharp rise in the adoption of UAVs for professional and leisure applications, which has resulted in the increasing concerns regarding aerial attacks among public and government. Such threats have contributed significantly towards the evolution of counter-drone measures. Several public safety departments as well as commercial establishments across the globe are increasingly deploying anti-drone systems in order to address the growing need for security.

UAVs are increasingly used for various illicit and undercover activities, such as smuggling contraband and spying. Although several prototypes have been developed to counter one UAV at a time, prominent manufacturers in the market are focusing on developing advanced solutions to counter simultaneous threats from multiple aircraft systems.

Click the link below:
https://www.grandviewresearch.com/industry–analysis/anti-drone-market

Further key findings from the study suggest:

  • There have been numerous instances of drones being used for illicit activities over the past years. Their detection and mitigation become critical concerns due to their small size and footprint
  • Military and defense is anticipated to emerge as the dominating end use sector over the next few years. Rise in the use of UAVs for smuggling and border trespassing, along with increasing R&D activities by defense prime contractors, has fueled the segment growth over the past few years
  • Innovative technologies such as radar and acoustic-based detection are increasingly implemented for the identification and classification of small unmanned aerial vehicles that are invisible to the naked eye
  • Significant investments have been made in the development of safer and effective anti-drone technologies by major venture capital firms
  • The Anti-drone market in Asia Pacific is expected to witness significant growth owing to increasing government expenditure on the expansion of the aerospace and defense infrastructure, especially in the emerging economies.

U.S. MVNO Market Size Worth $32.19 Billion By 2025

The U.S. mobile virtual network operator (MVNO) market size is expected to reach USD 32.19 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.2% CAGR during the forecast period. Increasing demand for value-added services (VAS) over voice services has led to a rise in the adoption of MVNO in U.S.

Increasing demand for roaming MVNO model owing to rise in number of travelers in the country has greatly propelled the U.S. MVNO market over the forecast period. Additionally, MVNO operators have been offering service sets at lower costs, which is expected to considerably aid market growth.

Soaring demand for smartphones and mobile broadband, along with technological advancements and development of compact, lightweight, and multifunctional devices, is anticipated to significantly drive the U.S. market. Expansion of communication technologies such as LTE 4G and 5G as well as expansion of Wi-Fi offer growth opportunities for players.

A key trend that has been observed in the U.S. market is that MVNOs in the country allow their users to personalize their plans for meeting text, data, and voice demands. Increasing advancements in LTE infrastructure, which provides services such as VoLTE, ViLTE, and VoWiFi, is expected to offer growth prospects to market players over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/us-mvno-market

Further key findings from the report suggest:

  • The U.S. MVNO market is expected to project a CAGR of 7.2% over the forecast period, owing to increasing number of mobile subscribers in the country
  • By type, the discount segment is anticipated to dominate the market, with a revenue of USD 7.73 billion in 2025. This growth can be attributed to intense competition in the market, which encourages MVNOs to offer various discounts on voice, data, and text to retain existing users and attract new ones
  • On the basis of operational mode, the full MVNO segment is expected to reach USD 19.35 billion by 2025, owing to low capital investment required in setting it up
  • By way of end use, the consumer segment emerged dominant and is anticipated to register a CAGR of 7.0% over the forecast period. This growth can be attributed to growing advancements in high-speed mobile broadband and availability of low-cost smartphones in the market
  • Key industry participants include 7-Eleven Speak Out Wireless, AirVoice Wireless, Asahi Net, Boost Mobile LLC, CJ HelloVision Co. Ltd, and Cyfrowy Polsat SA.

Ingestible Sensors Market Worth $1.99 Billion By 2024

The global ingestible sensors market size is expected to reach USD 1.99 billion by 2024, according to a new report by Grand View Research, Inc. The market is anticipated to register a strong CAGR of 19.1% over the forecast period. Growing need for medical adherence and real-time monitoring of health along with rising prevalence of chronic diseases are some of the factors driving the market growth. Patient compliance is another key factor boosting the usage of ingestible sensors.

Simple procedure, user convenience, and minimal side effects are the factors leading to increased medical adherence by patients of all age groups, thus, driving the market growth. Increasing cases of chronic diseases, such as diabetes, hypertension, and cancer have also led to the market expansion. According to the International Diabetes Federation (IDF), around 642 million people across the world are projected to have diabetes by 2040.

In addition, growing geriatric population is also leading to numerous health issues, which is further raising the incidences of such chronic diseases. With technological advancements, ingestible sensors are growing rapidly in the field of digital medicine. Thus, it is anticipated to grow further in applications like customized drug delivery. However, costly raw materials and techniques for the development and design of this product may impede the market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ingestible-sensors-market

Further key findings from the study suggest:

  • In 2016, temperature sensors led the market owing to their benefits in diagnosing and treating heat-related illness, particularly among athletes
  • Image sensors are projected to show a significant growth over the forecast period due to their accuracy and clear images for the diagnosis of critical diseases
  • Sensors held the largest market share in 2016 amongst the component segment due to the advanced and expensive technology used in these devices
  • Medical segment accounted for the largest market share in 2016 owing to huge scope of application for ingestible sensors in drug delivery and patient monitoring
  • North America held the largest market revenue in 2016 due to high awareness levels regarding the availability of advanced technologies
  • Asia Pacific is anticipated to register a significant CAGR over the forecast period on account of increasing geriatric population and prevalence of chronic diseases, especially in the developing countries
  • Some of the key companies in the market are Proteus Digital Healthcare; CapsoVision Inc.; Given Imaging Ltd; Olympus Corporation; Medimetrics Inc.; HQ Inc.; MC10 Inc.; and Microchips Biotech Inc.

Bioinformatics Services Market Worth $4.1 Billion By 2024

Global bioinformatics services market is anticipated to reach USD 4.1 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of I.T. solutions for different studies such as cell signaling, pathway metabolism, gene-receptor interactions, and target differentiation are expected to support growth in this market over the forecast period.

Owing to the benefits associated with the use of informatic solutions for laboratory protocol generation and data management as well as analysis, these solutions are projected to witness substantial demand in the coming years.

Moreover, collaborative activities undertaken by the information technology companies with pharmaceutical companies and clinical research organizations in order to develop and update key technologies linked to cloud computing, like online data storage and visualization of computer resources are expected to enhance market potential through to 2024.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/bioinformatics-services-market

Further key findings from the report suggest:

  • NGS is estimated to be the dominant segment with respect to the type of service served in 2015 owing to the fact that sequence-based approach of analysis can be cataloged with the structure-based approach as complementary to genomic and proteomic approaches. Advancement in the sequencing technologies such as NGS and scripting tools (Perl & Python) for sequence manipulation coupled with the reduction in prices of the sequencing platforms and market movement towards the USD 1,000 genome resulted in a larger revenue share of this segment in the discovery informatics.
  • Market revenue from of chemoinformatics is second only to NGS and its strong market position can be accounted for by presence of several entities operating in this segment and their involvement in the provision of lead identification, validation, assay development, lead generation, optimization, and clinical trial based informatic solutions.
  • Depending on the application, transcriptomics is anticipated to register the fastest growth of over 15% owing to rise in the number of projects carried out in translational research and application of RNA transcripts for studying etiology of chronic as well as acute diseases.
  • Academic sector, in terms of end-use for these services, is expected to witness the fastest growth through to 2024 as a result of rise in the adoption rate of these technologies in genomic, proteomic and metabolomics research programs carried out by universities research institutes. If not all, most of these programs are either backed through government funding or private corporation backing and forms a considerable part of the high R&D investment that the bioinformatics market attracts in the current scenario.
  • North America dominated the industry in 2015, accounting for a little 35% of total revenue. Presence of key participants operating in the region which are involved in development of novel algorithms and software in order to improve drug attrition rates which consequently increases adoption rate of computational algorithms is attributive for the largest share of North America in sector revenue. Demand for informatic services in Europe is also increasing owing to the presence of universities in Germany and UK that are involved in development of I.T. solutions for pharmaceutical research.
  • Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the fact that government and regulatory authorities have implemented a framework to encourage R&D collaborations and framework extension. Active expansion strategies undertaken by a number of the major market entities operating in the American market in order to strengthen their position in Asia Pacific region is a factor anticipated to consequently drive growth.
  • Key players operating in this industry include Agilent technologies, Siegen Inc., GVK Biosciences, Accelerys Inc, Illumina Inc., DNAnexus, Life Technologies Corporation, Geneva Bioinformatic, Celera Corporation, IBM Life sciences, and Affymetrix.
  • These entities are adopting strategies such as collaborations with pharmaceutical and biotechnology companies in order to enhance industrial presence by providing different data management and analytical services for the purpose of drug design and therapeutic monitoring.